🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
The combination of chemotherapy with PD-1 immune checkpoint blockade agents...
Status
Active Not Recruiting
Location
Institut Jules Bordet
Start Date
2018-12-28
Trial ID
NCT03616886
Treatments Being Tested
This study is designed to determine the efficacy and safety of durvalumab i...
Status
Active Not Recruiting
Location
Research Site
Start Date
2018-12-21
Trial ID
NCT03742102
Treatments Being Tested
The study is intended to assess the safety and efficacy of perioperative tr...
Status
Recruiting
Location
Research Site
Start Date
2022-04-14
Trial ID
NCT05061550
The objective of this study is to investigate the safety, tolerability, and...
Status
Active Not Recruiting
Location
Research Site
Start Date
2018-05-08
Trial ID
NCT03381274
Treatments Being Tested
This study is designed to determine the efficacy and safety of durvalumab a...
Status
Active Not Recruiting
Location
Research Site
Start Date
2018-12-27
Trial ID
NCT03819465
This is a multi-site Canadian, window of opportunity study to evaluate the ...
Status
Recruiting
Location
Princess Margaret Cancer Centre
Start Date
2023-11-29
Trial ID
NCT06060405
Treatments Being Tested
This is an open-label Phase II modular study in participants with prostate ...
Status
Completed
Location
Research Site
Start Date
2019-08-29
Trial ID
NCT04089553
Treatments Being Tested
The overall objectiv is to obtain preliminary evidence of efficacy of novel...
Status
Completed
Location
Rigshospitalet
Start Date
2018-05-14
Trial ID
NCT03267589
Treatments Being Tested
The purpose of this study is to Evaluate the Safety, Tolerability, Pharmaco...
Status
Completed
Location
Research Site
Start Date
2015-07-24
Trial ID
NCT02503774
Treatments Being Tested
This is an open-label, multi-centre, umbrella Phase II study in participant...
Status
Active Not Recruiting
Location
Research Site
Start Date
2017-12-18
Trial ID
NCT03334617
Treatments Being Tested